Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmacia Biotech was a premier global provider of technologies and solutions for the life sciences industry, specializing in the separation and purification of biomolecules. The company is best known for developing industry-standard products such as Sephadex chromatography resins and the ÄKTA line of protein purification systems. Originally a division of the Swedish firm Pharmacia, the entity played a critical role in the advancement of biotechnology by providing the tools necessary for large-scale biopharmaceutical manufacturing. Following a series of high-profile mergers and acquisitions, including a merger with Amersham Life Science in 1997, the business eventually became part of GE Healthcare. In 2020, the division was acquired by Danaher Corporation and rebranded as Cytiva, where its legacy technologies continue to support the production of modern therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmacia Biotech.